Intriguingly, the cytotoxicity of peripheral blood lymphocytes of patients elevated significantly during treatment, demonstrating that the IL-7-expressing tumor cell vaccine was immunological and capable to stimulate a robust immune response against metastatic cancers. The gene discussed is IL7; the disease is neoplasm.